BBNX vs ECL · rev $65.1M vs P/E 35, rev $4.01B
Beta Bionics, Inc. Common Stock (BBNX) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported BBNX revenue for 2024-12-31 was $65.1M. Net income was -$54.8M. Revenue was up 442.9% from 2023-12-31 to 2024-12-31. BBNX currently screens at market cap $640.8M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
BBNX currently screens at market cap $640.8M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the BBNX and ECL stock pages for the full models.
Not investment advice.